MODULATION OF EMOTIONS USING BOTULINUM TOXIN IN INDIVIDUALS WITHOUT PSYCHIATRIC DISORDERS: A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5408Keywords:
Botulinum Toxin, Emotional Modulation, Facial Feedback, Well-BeingAbstract
Aim: This review aims to discuss the mechanisms by which reducing facial muscle activity in the glabellar region may influence emotional processing and regulation in individuals without diagnosed mental disorders.
Material and Methods: A literature search was conducted using MedLine/PubMed databases in both Polish and English. Additionally, reference lists of selected articles were screened to identify further relevant studies.
Results: Botulinum toxin exerts its effect by blocking acetylcholine release at the neuromuscular junction, resulting in temporary muscle paralysis. According to the facial feedback hypothesis, facial expressions not only reflect emotions but also influence their experience and regulation. Limiting the activity of muscles responsible for negative emotional expressions may modulate subjective emotional experience. Available studies suggest that botulinum toxin injections in the glabellar region may be associated with improved mood and increased subjective well-being in individuals without psychiatric disorders.
Conclusions: Botulinum toxin may influence emotional regulation by altering feedback from facial muscles in individuals without mental disorders. However, high-quality studies are still needed to confirm these findings.
References
Darwin, C. (1872). The expression of the emotions in man and animals. Oxford University Press.
Strack, F., Martin, L. L., & Stepper, S. (1988). Inhibiting and facilitating conditions of the human smile: A nonobtrusive test of the facial feedback hypothesis. Journal of Personality and Social Psychology, 54(5), 768–777. https://doi.org/10.1037/0022-3514.54.5.768
Larsen, R. J., Kasimatis, M., & Frey, K. (1992). Facilitating the furrowed brow: An unobtrusive test of the facial feedback hypothesis applied to unpleasant affect. Cognition and Emotion, 6, 321–338. https://doi.org/10.1080/02699939208409696
Monheit, G. D., & Pickett, A. (2017). AbobotulinumtoxinA: A 25-year history. Aesthetic Surgery Journal, 37(Suppl. 1), S4–S11. https://doi.org/10.1093/asj/sjw284
Finzi, E., & Wasserman, E. (2006). Treatment of depression with botulinum toxin A: A case series. Dermatologic Surgery, 32, 645–650. https://doi.org/10.1111/j.1524-4725.2006.32136.x
Zhu, C., Wang, K., Yu, T., & Liu, H. (2021). Effects of botulinum toxin type A on mood and cognitive function in patients with Parkinson's disease and depression. American Journal of Translational Research, 13, 2717–2723.
Li, Y., Zhu, T., Shen, T., Wu, W., Cao, J., Sun, J., et al. (2022). Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo-controlled trial. Journal of Affective Disorders, 318, 48–53. https://doi.org/10.1016/j.jad.2022.08.098
Schwartz, G. E., Fair, P. L., Salt, P., Mandel, M. R., & Klerman, G. L. (1976). Facial muscle patterning to affective imagery in depressed and nondepressed subjects. Science, 192, 489–491. https://doi.org/10.1126/science.775637
Lundqvist, L. O. (1995). Facial EMG reactions to facial expressions: A case of facial emotional contagion? Scandinavian Journal of Psychology, 36(2), 130–141. https://doi.org/10.1111/j.1467-9450.1995.tb00974.x
Hennenlotter, A., Dresel, C., Castrop, F., Ceballos-Baumann, A. O., Wohlschläger, A. M., & Haslinger, B. (2009). The link between facial feedback and neural activity within central circuitries of emotion: New insights from botulinum toxin-induced denervation of frown muscles. Cerebral Cortex, 19, 537–542. https://doi.org/10.1093/cercor/bhn104
Kim, M. J., Neta, M., Davis, F. C., Ruberry, E. J., Dinescu, D., Heatherton, T. F., et al. (2014). Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: Preliminary findings from an A-B-A design. Biology of Mood & Anxiety Disorders, 4, Article 11. https://doi.org/10.1186/2045-5380-4-11
Lanteaume, L., Khalfa, S., Régis, J., Marquis, P., Chauvel, P., & Bartolomei, F. (2007). Emotion induction after direct intracerebral stimulations of human amygdala. Cerebral Cortex, 17, 1307–1313. https://doi.org/10.1093/cercor/bhl041
Ekman, P., Davidson, R. J., & Friesen, W. V. (1990). The Duchenne smile: Emotional expression and brain physiology II. Journal of Personality and Social Psychology, 58(2), 342–353. https://doi.org/10.1037/0022-3514.58.2.342
Nowińska, M., Kozyra, M., Raczkiewicz, P., Kaczerska, M., Śmiech, N., & Milanowska, J. (2021). Botox or the new face of the fight against depression: Literature review. Journal of Education, Health and Sport, 11(8), 268–275.
Hanayama, H., Tada, J., & Terashi, H. (2024). Botulinum toxin A therapy for glabellar lines improves emotional states: Evaluation of 47 cases without mental disorders. Journal of Plastic and Reconstructive Surgery, 4(2), 75–80. https://doi.org/10.53045/jprs.2023-0057
Lewis, M. B. (2018). The interactions between botulinum-toxin-based facial treatments and embodied emotions. Scientific Reports, 8, Article 14720. https://doi.org/10.1038/s41598-018-33119-1
Lewis, M. B., & Bowler, P. J. (2009). Botulinum toxin cosmetic therapy correlates with a more positive mood. Journal of Cosmetic Dermatology, 8(1), 24–26. https://doi.org/10.1111/j.1473-2165.2009.00419.x
Hirsch, J., Zhang, X., Noah, J. A., & Bhattacharya, A. (2023). Neural mechanisms for emotional contagion and spontaneous mimicry of live facial expressions. Philosophical Transactions of the Royal Society B, 378. https://doi.org/10.1098/rstb.2021.0348
Japee, S. (2024). On the role of sensorimotor experience in facial expression perception. Journal of Cognitive Neuroscience. https://doi.org/10.1162/jocn_a_02015
Reichenberg, J. S., Hauptman, A. J., Robertson, H. T., Finzi, E., Kruger, T. H., Wollmer, M. A., et al. (2016). Botulinum toxin for depression: Does patient appearance matter? Journal of the American Academy of Dermatology, 74(1), 171–173.e1. https://doi.org/10.1016/j.jaad.2015.08.051
Sommer, B., Zschocke, I., Bergfeld, D., et al. (2003). Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatologic Surgery, 29(5), 456–460.
Hexsel, D., Brum, C., Siega, C., et al. (2013). Evaluation of self-esteem and depression symptoms in depressed and nondepressed subjects treated with onabotulinumtoxinA for glabellar lines. Dermatologic Surgery, 39(7), 1088–1096. https://doi.org/10.1111/dsu.12216
Alam, M., Barrett, K. C., Hodapp, R. M., et al. (2008). Botulinum toxin and the facial feedback hypothesis: Can looking better make you feel happier? Journal of the American Academy of Dermatology, 58(6), 1061–1072. https://doi.org/10.1016/j.jaad.2008.01.022
Davis, J. I., Senghas, A., Brandt, F., & Ochsner, K. N. (2010). The effects of BOTOX injections on emotional experience. Emotion, 10(3), 433–440. https://doi.org/10.1037/a0018690
Havas, D. A., Glenberg, A. M., Gutowski, K. A., Lucarelli, M. J., & Davidson, R. J. (2010). Cosmetic use of botulinum toxin-A affects processing of emotional language. Psychological Science, 21(7), 895–900. https://doi.org/10.1177/0956797610374742
Nestor, M. S., Fischer, D. L., & Arnold, D. (2020). Masking our emotions: Botulinum toxin, facial expression, and well-being in the age of COVID-19. Journal of Cosmetic Dermatology, 19(9), 2154–2160. https://doi.org/10.1111/jocd.13569
Baumeister, J. C., Papa, G., & Foroni, F. (2016). Deeper than skin deep: The effect of botulinum toxin-A on emotion processing. Toxicon, 118, 86–90. https://doi.org/10.1016/j.toxicon.2016.04.044
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Klaudia Czech, Duszan Leja, Zuzanna Michalik, Klaudia Kapelka, Stanisław Malik, Przemysław Paduch, Zofia Bułka, Joanna Mazur, Dawid Kłos, Kaja Zdrojewska, Lena Apanowicz, Klaudia Gogół-Fijał

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

